Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-11-14

Clinical Trial Update: A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump [Phase 1]

View source ↗

Summary

The Phase 1 pharmacokinetic study evaluating gonadotropin-releasing hormone delivered by the OmniPod pump has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gonadotropin-releasing hormone (Gonadotropin-releasing hormone)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Amenorrhea, Fertility | Phase 1 | Status: WITHDRAWN